TY - JOUR
T1 - Correction to
T2 - A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease (Alzheimer's Research and Therapy (2017) 9 (95) DOI: 10.1186/s13195-017-0318-y)
AU - Ostrowitzki, Susanne
AU - Lasser, Robert A.
AU - Dorflinger, Ernest
AU - Scheltens, Philip
AU - Barkhof, Frederik
AU - Nikolcheva, Tania
AU - Ashford, Elizabeth
AU - Retout, Sylvie
AU - Hofmann, Carsten
AU - Delmar, Paul
AU - Klein, Gregory
AU - Andjelkovic, Mirjana
AU - Dubois, Bruno
AU - Boada, Mercè
AU - Blennow, Kaj
AU - Santarelli, Luca
AU - Fontoura, Paulo
PY - 2018
Y1 - 2018
N2 - Following publication of the original article [1], the author reported errors in the formatting of the table. The details of the errors are as follows: In Table 1, the data presented do not correspond to the row title: The education row currently contains incorrect data. The weight row currently contains the years of education. The APOE 4 genotype row currently contains the weight data. In Table 1, the data should be displayed as follows: Variable Intention-to-treat population (n = 797) Placebo (n = 266) Gantenerumab 105 mg (n = 271) Gantenerumab 225 mg (n = 260) Age, years, mean (SD) 69.5 (7.5) 70.3 (7.0) 71.3 (7.1) Education, years, mean (SD) 12.6 (4.3)12.9 (4.8) 12.1 (4.5) Weight, kg, mean (SD) 69.8 (12.9) 70.5 (13.6) 70.1 (12.5) APOE4 genotype, %a.
AB - Following publication of the original article [1], the author reported errors in the formatting of the table. The details of the errors are as follows: In Table 1, the data presented do not correspond to the row title: The education row currently contains incorrect data. The weight row currently contains the years of education. The APOE 4 genotype row currently contains the weight data. In Table 1, the data should be displayed as follows: Variable Intention-to-treat population (n = 797) Placebo (n = 266) Gantenerumab 105 mg (n = 271) Gantenerumab 225 mg (n = 260) Age, years, mean (SD) 69.5 (7.5) 70.3 (7.0) 71.3 (7.1) Education, years, mean (SD) 12.6 (4.3)12.9 (4.8) 12.1 (4.5) Weight, kg, mean (SD) 69.8 (12.9) 70.5 (13.6) 70.1 (12.5) APOE4 genotype, %a.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85054090845&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/30261916
U2 - https://doi.org/10.1186/s13195-018-0409-4
DO - https://doi.org/10.1186/s13195-018-0409-4
M3 - Erratum/Corrigendum
C2 - 30261916
SN - 1758-9193
VL - 10
JO - Alzheimer's Research and Therapy
JF - Alzheimer's Research and Therapy
IS - 1
M1 - 99
ER -